The US Food and Drug Administration (FDA) has dispatched warning letters to 15 firms, including foreign and domestic to desist from selling their illegally marketed diabetes products. The latest move will help the regulator to curb the ...
Tags: Diabetes'Medicines, active pharma
Omkar Speciality Chemicals has advanced into pharmaceutical business with the acquisition of LASA Laboratory, which consists of an API manufacturing facility. The purchase is expected to allow the company to focus on manufacturing ...